Bacillus Calmette-Guérin (BCG) is a puny cousin of the bacteria that causes tuberculosis, and as such serves as an excellent vaccine against the disease. But BCG is also used to treat bladder cancer.

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA ...

Bladder cancer occurs when cells in the bladder — a water balloon–like organ in the lower abdomen that stores urine — grow out of control. There are many treatment options for bladder cancer ...

BCG, the century-old TB vaccine, is derived from the live ... The U.S. Food and Drug Administration has approved it for the treatment of bladder cancer. Yet, the potential effect of BCG in ...

Bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is widely administered as a vaccine for tuberculosis. BCG is also used as a biotherapy for superficial bladder carcinoma.

bladder cancer had significantly less risk of cancer progressing or returning when treated with durvalumab, and were more likely to still be alive two years after treatment. Experts from the ...

Study co-lead investigator Dr James Catto, professor of urology at Sheffield and honorary consultant urological surgeon, said: “This is a major breakthrough in the treatment of bladder cancer.